Perrigo Company plc has agreed to acquire Héra SAS (HRA Pharma), a French consumer self-care company, from funds affiliated with Astorg and Goldman Sachs Asset Management for around $2.1 billion in cash. HRA Pharma is an over-the-counter (OTC) company, which owns specialist blister plaster brand Compeed, ellaOne emergency contraception brand, and Mederma scar care cream. […]
BirchBioMed has reported positive results from a phase 2 trial evaluating the use of topical FS2, the company’s antifibrotic platform therapy, in the treatment of keloid scars. The Canadian clinical-stage immunology company said that the double-blind study delivered statistically significant results compared to Mederma, a market leading scar cream and a vehicle (placebo cream) in […]
